429 related articles for article (PubMed ID: 12210430)
21. Mutations of T-cell epitopes in the hepatitis B virus surface gene in children with chronic infection and hepatocellular carcinoma.
Ni YH; Chang MH; Hsu HY; Tung YC; Chen HL; Wang KJ; Tsuei DJ; Young NC
Am J Gastroenterol; 2008 Apr; 103(4):1004-9. PubMed ID: 18190649
[TBL] [Abstract][Full Text] [Related]
22. Virological outcomes in patients infected chronically with hepatitis B virus genotype A in comparison with genotypes B and C.
Kobayashi M; Akuta N; Suzuki F; Suzuki Y; Arase Y; Ikeda K; Hosaka T; Saitoh S; Kobayashi M; Someya T; Sato J; Watabiki S; Miyakawa Y; Kumada H
J Med Virol; 2006 Jan; 78(1):60-7. PubMed ID: 16299721
[TBL] [Abstract][Full Text] [Related]
23. Hepatitis B virus genotype D prevails in patients with persistently elevated or normal ALT levels in Turkey.
Yalcin K; Degertekin H; Bahcecioglu IH; Demir A; Aladag M; Yildirim B; Horasanli S; Ciftci S; Badur S
Infection; 2004 Feb; 32(1):24-9. PubMed ID: 15007739
[TBL] [Abstract][Full Text] [Related]
24. Clinical significance of pre-S mutations in patients with genotype C hepatitis B virus infection.
Choi MS; Kim DY; Lee DH; Lee JH; Koh KC; Paik SW; Rhee JC; Yoo BC
J Viral Hepat; 2007 Mar; 14(3):161-8. PubMed ID: 17305881
[TBL] [Abstract][Full Text] [Related]
25. Fine mapping of hepatitis B virus pre-S deletion and its association with hepatocellular carcinoma.
Kao JH; Liu CJ; Jow GM; Chen PJ; Chen DS; Chen BF
Liver Int; 2012 Oct; 32(9):1373-81. PubMed ID: 22676233
[TBL] [Abstract][Full Text] [Related]
26. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K
Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524
[TBL] [Abstract][Full Text] [Related]
27. Naturally occurring MHR variants in Turkish patients infected with hepatitis B virus.
Sayiner AA; Ozcan A; Sengonul A
J Med Virol; 2008 Mar; 80(3):405-10. PubMed ID: 18205223
[TBL] [Abstract][Full Text] [Related]
28. Non-sequencing molecular approaches to identify preS2-defective hepatitis B virus variants proved to be associated with severe liver diseases.
Raimondo G; Costantino L; Caccamo G; Pollicino T; Squadrito G; Cacciola I; Brancatelli S
J Hepatol; 2004 Mar; 40(3):515-9. PubMed ID: 15123368
[TBL] [Abstract][Full Text] [Related]
29. Mutations within the hepatitis B virus genome among chronic hepatitis B patients with hepatocellular carcinoma.
Bläckberg J; Kidd-Ljunggren K
J Med Virol; 2003 Sep; 71(1):18-23. PubMed ID: 12858404
[TBL] [Abstract][Full Text] [Related]
30. Viral and clinical factors associated with surface gene variants among hepatitis B virus carriers.
Roque-Afonso AM; Férey MP; Ly TD; Graube A; Costa-Faria L; Samuel D; Dussaix E
Antivir Ther; 2007; 12(8):1255-63. PubMed ID: 18240865
[TBL] [Abstract][Full Text] [Related]
31. Identification and characterization of a prevalent hepatitis B virus X protein mutant in Taiwanese patients with hepatocellular carcinoma.
Yeh CT; Shen CH; Tai DI; Chu CM; Liaw YF
Oncogene; 2000 Nov; 19(46):5213-20. PubMed ID: 11077437
[TBL] [Abstract][Full Text] [Related]
32. Role of hepatitis B viral load and basal core promoter mutation in hepatocellular carcinoma in hepatitis B carriers.
Liu CJ; Chen BF; Chen PJ; Lai MY; Huang WL; Kao JH; Chen DS
J Infect Dis; 2006 May; 193(9):1258-65. PubMed ID: 16586363
[TBL] [Abstract][Full Text] [Related]
33. Hepatitis B virus surface protein mutations clustered mainly in CTL immune epitopes in chronic carriers: results of an Iranian nationwide study.
Khedive A; Norouzi M; Ramezani F; Karimzadeh H; Alavian SM; Malekzadeh R; Montazeri G; Nejatizadeh A; Ziaee M; Abedi F; Ataei B; Yaran M; Sayad B; Somi MH; Sarizadeh G; Sanei-Moghaddam I; Mansour-Ghanaei F; Rafatpanah H; Pourhosseingholi MA; Keyvani H; Kalantari E; Saberifiroozi M; Judaki MA; Ghamari S; Daram M; Mahabadi M; Fazeli Z; Goodarzi Z; Poortahmasebi V; Jazayeri SM
J Viral Hepat; 2013 Jul; 20(7):494-501. PubMed ID: 23730843
[TBL] [Abstract][Full Text] [Related]
34. Molecular and clinical characteristics of hepatitis B virus in Korea.
Ahn SH; Yuen L; Han KH; Littlejohn M; Chang HY; Damerow H; Ayres A; Heo J; Locarnini S; Revill PA
J Med Virol; 2010 Jul; 82(7):1126-34. PubMed ID: 20513074
[TBL] [Abstract][Full Text] [Related]
35. Association of concurrent hepatitis B surface antigen and antibody to hepatitis B surface antigen with hepatocellular carcinoma in chronic hepatitis B virus infection.
Jang JS; Kim HS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Kim DJ; Lee MS; Park CK; Jeong BH; Kim YS; Jang MK
J Med Virol; 2009 Sep; 81(9):1531-8. PubMed ID: 19623669
[TBL] [Abstract][Full Text] [Related]
36. Basal core-promoter mutant of hepatitis B virus and progression of liver disease in hepatitis B e antigen-negative chronic hepatitis B.
Lin CL; Liao LY; Wang CS; Chen PJ; Lai MY; Chen DS; Kao JH
Liver Int; 2005 Jun; 25(3):564-70. PubMed ID: 15910494
[TBL] [Abstract][Full Text] [Related]
37. Differential integration rates of hepatitis B virus DNA in the liver of children with chronic hepatitis B virus infection and hepatocellular carcinoma.
Huang HP; Tsuei DJ; Wang KJ; Chen YL; Ni YH; Jeng YM; Chen HL; Hsu HY; Chang MH
J Gastroenterol Hepatol; 2005 Aug; 20(8):1206-14. PubMed ID: 16048568
[TBL] [Abstract][Full Text] [Related]
38. Circulating hepatitis B virus nucleic acids in chronic infection : representation of differently polyadenylated viral transcripts during progression to nonreplicative stages.
Su Q; Wang SF; Chang TE; Breitkreutz R; Hennig H; Takegoshi K; Edler L; Schröder CH
Clin Cancer Res; 2001 Jul; 7(7):2005-15. PubMed ID: 11448918
[TBL] [Abstract][Full Text] [Related]
39. Virological significance of low-level hepatitis B virus infection in patients with hepatitis C virus associated liver disease.
Tanaka T; Inoue K; Hayashi Y; Abe A; Tsukiyama-Kohara K; Nuriya H; Aoki Y; Kawaguchi R; Kubota K; Yoshiba M; Koike M; Tanaka S; Kohara M
J Med Virol; 2004 Feb; 72(2):223-9. PubMed ID: 14695663
[TBL] [Abstract][Full Text] [Related]
40. Occult hepatitis B viral DNA in liver carcinomas from a region with a low prevalence of chronic hepatitis B infection.
Kannangai R; Molmenti E; Arrazola L; Klein A; Choti M; Thomas DL; Torbenson M
J Viral Hepat; 2004 Jul; 11(4):297-301. PubMed ID: 15230851
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
